FDA approves Radius Health's osteoporosis drug Tymlos

(Reuters) - The U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies.

U.S. FDA approves Takeda's lung cancer drug as second-line treatment

(Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Friday that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the company acquired the drug's developer, Ariad Pharmaceuticals Inc.

Mexican Congress approves use of medical marijuana

MEXICO CITY (Reuters) - Mexico's Lower House of Congress passed a bill on Friday to legalize the use of marijuana and cannabis for medical and scientific needs, a step closer to outright legalization in a country long scarred by warring drug cartels.

Is active surveillance safe for men with family history of prostate cancer?

(Reuters Health) - Having a family history of prostate cancer doesn’t make it more risky for men with a new diagnosis of the disease to initially hold off on active treatment in favor of monitoring with periodic lab tests, a research review suggests.

With Obamacare in doubt, California asks insurers to double up on rate filings

NEW YORK (Reuters) - Health insurers seeking regulatory approval for 2018 individual insurance plans can file two sets of premium rates as a way to deal with market uncertainty created by Republicans' promise to repeal and replace Obamacare, a California state insurance regulator said on Friday.

Rethink emphasis on lowering saturated fat to save hearts: docs

(Reuters Health) - Instead of eating less saturated fat and worrying about so-called bad cholesterol, a group of doctors suggests an alternative approach for preventing heart disease.

Doctors should consider whether older patients can hear them

(Reuters Health) - Elderly people with hearing loss may have difficulty understanding speech in noisy healthcare settings - and the situation isn't helped when doctors speak fast and use medical jargon, experts say.

Malaria, wiped out in U.S., still plagues American travelers

(Reuters Health) - U.S. public health officials declared victory over malaria in 1951, but the mosquito-borne disease continues to infect and kill American travelers, a new study shows.

Home blood pressure monitors may not be accurate enough

(Reuters Health) – Even as doctors are increasingly relying on home blood pressure monitoring to manage patients with hypertension, many of the devices are too inaccurate to be useful, according to a small study.

FDA approves Novartis' leukemia treatment

(Reuters) - The U.S. Food and Drug Administration on Friday approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML).

Global med-tech firms, India locked in tussle after stent price sting

NEW DELHI/MUMBAI (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for

Mystery deaths in Liberia linked to funeral: WHO

GENEVA (Reuters) - Nine people have died and eight are sick in Liberia after attending the funeral of a religious leader, the World Health Organization (WHO) said on Friday.

UK cancer fund was poor value and may have caused patient suffering

LONDON (Reuters) - A special U.K. Cancer Drugs Fund (CDF) set up in 2010 spent over 1.2 billion pounds ($1.55 bln) but failed to deliver value for patients or society and may have caused unnecessary suffering, an analysis has found.